Amalgamated Bank Ionis Pharmaceuticals Inc Transaction History

Amalgamated Bank

  • $11.7 Billion
  • Q1 2025

A detailed history of Amalgamated Bank transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Amalgamated Bank holds 10,573 shares of IONS stock, worth $388,663. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,573
Previous 10,292 2.73%
Holding current value
$388,663
Previous $360,000 11.39%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 25, 2025
BUY
$30.17 - $34.97 $8,477 - $9,826
281 Added 2.73%
10,573 $319,000
Q4 2024

Feb 04, 2025
BUY
$33.73 - $40.36 $11,299 - $13,520
335 Added 3.36%
10,292 $360,000
Q3 2024

Oct 30, 2024
BUY
$40.06 - $51.86 $12,018 - $15,558
300 Added 3.11%
9,957 $399,000
Q2 2024

Aug 12, 2024
BUY
$36.45 - $47.7 $16,548 - $21,655
454 Added 4.93%
9,657 $460,000
Q1 2024

Apr 23, 2024
SELL
$42.03 - $53.55 $831,857 - $1.06 Million
-19,792 Reduced 68.26%
9,203 $399,000
Q4 2023

Feb 06, 2024
SELL
$43.39 - $51.63 $3,948 - $4,698
-91 Reduced 0.31%
28,995 $1.47 Million
Q3 2023

Nov 08, 2023
SELL
$38.5 - $47.13 $14,360 - $17,579
-373 Reduced 1.27%
29,086 $1.32 Million
Q2 2023

Aug 11, 2023
BUY
$34.73 - $43.33 $12,190 - $15,208
351 Added 1.21%
29,459 $1.21 Million
Q1 2023

May 02, 2023
SELL
$33.58 - $41.2 $100,303 - $123,064
-2,987 Reduced 9.31%
29,108 $1.04 Million
Q4 2022

Feb 10, 2023
BUY
$37.12 - $46.52 $18,671 - $23,399
503 Added 1.59%
32,095 $1.21 Million
Q3 2022

Nov 09, 2022
SELL
$36.54 - $48.66 $63,250 - $84,230
-1,731 Reduced 5.19%
31,592 $1.4 Million
Q2 2022

Aug 15, 2022
BUY
$31.71 - $43.0 $44,045 - $59,727
1,389 Added 4.35%
33,323 $1.23 Million
Q1 2022

Jun 30, 2022
BUY
$29.88 - $37.04 $77,986 - $96,674
2,610 Added 8.9%
31,934 $1.18 Million
Q4 2021

Feb 15, 2022
BUY
$25.61 - $35.1 $100,468 - $137,697
3,923 Added 15.44%
29,324 $892,000
Q3 2021

Oct 29, 2021
SELL
$33.54 - $40.55 $51,383 - $62,122
-1,532 Reduced 5.69%
25,401 $852,000
Q2 2021

Aug 16, 2021
BUY
$34.54 - $47.25 $251,002 - $343,365
7,267 Added 36.95%
26,933 $1.07 Million
Q1 2021

May 13, 2021
SELL
$42.51 - $63.78 $67,420 - $101,155
-1,586 Reduced 7.46%
19,666 $884,000
Q4 2020

Feb 12, 2021
SELL
$45.3 - $60.27 $1,268 - $1,687
-28 Reduced 0.13%
21,252 $1.2 Million
Q3 2020

Oct 30, 2020
SELL
$47.45 - $62.95 $15,136 - $20,081
-319 Reduced 1.48%
21,280 $1.01 Million
Q2 2020

Aug 10, 2020
SELL
$46.85 - $61.05 $567,166 - $739,071
-12,106 Reduced 35.92%
21,599 $1.27 Million
Q1 2020

May 13, 2020
SELL
$41.6 - $63.4 $38,729 - $59,025
-931 Reduced 2.69%
33,705 $1.59 Million
Q4 2019

Feb 13, 2020
BUY
$53.85 - $65.27 $115,723 - $140,265
2,149 Added 6.61%
34,636 $2.09 Million
Q3 2019

Nov 13, 2019
BUY
$59.06 - $72.15 $247,756 - $302,669
4,195 Added 14.83%
32,487 $1.95 Million
Q2 2019

Aug 14, 2019
SELL
$62.09 - $86.14 $6,705 - $9,303
-108 Reduced 0.38%
28,292 $1.82 Million
Q1 2019

May 15, 2019
BUY
$52.92 - $81.17 $27,571 - $42,289
521 Added 1.87%
28,400 $2.31 Million
Q4 2018

Feb 15, 2019
BUY
$43.37 - $59.54 $466,747 - $640,769
10,762 Added 62.87%
27,879 $1.51 Million
Q3 2018

Nov 14, 2018
SELL
$42.88 - $53.7 $516,661 - $647,031
-12,049 Reduced 41.31%
17,117 $883,000
Q2 2018

Jul 18, 2018
BUY
$40.53 - $50.7 $111,943 - $140,033
2,762 Added 10.46%
29,166 $1.22 Million
Q1 2018

May 22, 2018
BUY
$44.08 - $55.05 $75,024 - $93,695
1,702 Added 6.89%
26,404 $1.16 Million
Q4 2017

Feb 13, 2018
BUY
$50.3 - $64.39 $67,905 - $86,926
1,350 Added 5.78%
24,702 $1.24 Million
Q3 2017

Nov 09, 2017
BUY
$45.56 - $59.57 $1.06 Million - $1.39 Million
23,352
23,352 $1.18 Million

Others Institutions Holding IONS

# of Institutions
401
Shares Held
146M
Call Options Held
916K
Put Options Held
552K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.22B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email